Close
ACHEMA MIDDLE EAST 2026

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

The FDA has granted approval to begin clinical trials of the AD-NP1 drug. It is a first-in-class drug for tissue regeneration, which targets cellular...

US FDA Launches Fast-Track Review Scheme for Generic Drugs

The FDA has introduced a pilot fast-track review programme aimed at accelerating reviews for generic medicines tested and manufactured within the United States, marking...

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

Bristol Myers Squibb, Takeda Pharmaceuticals and Astex Pharmaceuticals have joined forces in a new collaboration that seeks to harness artificial intelligence to accelerate drug...

AbbVie Launches New API Manufacturing Facility in Illinois

AbbVie has started construction of a new active pharmaceutical ingredient (API) manufacturing facility in North Chicago, Illinois, a critical milestone in its strategy to...

Amgen to Expand U.S. Manufacturing with $650M Investment

Amgen has announced a $650 million expansion of its U.S. manufacturing facilities, a development that will create almost 750 new positions. The expansion will...

US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

Eli Lilly and Company has received U.S. Food and Drug Administration (FDA) approval for Inluriyo (imlunestrant, 200 mg tablets), an oral estrogen receptor antagonist....

Lilly to Build $6.5B API Manufacturing Facility in Houston

Eli Lilly and Company has unveiled plans for a $6.5 billion manufacturing facility in Generation Park, Houston, Texas. The project, described as a next-generation...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...